麻疹、腮腺炎和德國德國麻疹(MMR) 疫苗市場：依產品類型、最終用戶和地區分類

Measles, Mumps and Rubella (MMR) Vaccines Market, By Product Type, By End Users, By Geography

出版日期: 2026年07月31日 | 出版商:

Coherent Market Insights | 英文 258 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2026 年，麻疹、腮腺炎和德國德國麻疹(MMR) 疫苗市場規模將達到 42 億美元，到 2033 年將達到 58 億美元。預計從 2026 年到 2033 年，其複合年成長率將達到 6.1%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	42億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	6.10%	2033年市場規模預測：	58億美元

世界各國政府和醫療機構正透過加強免疫接種計畫和預防高傳染性病毒感染疾病的傳播，推動麻疹-腮腺炎-德國德國麻疹(MMR) 疫苗市場的成長。醫護人員接種 MMR 疫苗，以增強對麻疹、腮腺炎和德國麻疹的免疫力，並降低這些疾病的感染率。大眾對疫苗接種益處的認知不斷提高，對預防醫學的日益重視，以及全球為提高免疫接種率所做的努力，都在促進兒童、青少年和成人接種 MMR 疫苗。

政府的免疫接種宣傳活動、醫療保健領域投資的增加以及疫苗研發和分發技術的進步正在推動麻疹、腮腺炎、德國麻疹（MMR）疫苗市場的擴張。製藥公司正致力於提高疫苗的可及性，最佳化儲存和供應鏈解決方案，並擴大生產能力，以滿足大規模免疫接種計畫的需求。公共衛生機構正透過國際衛生宣傳活動加強控制麻疹疫情並提高疫苗接種率。這些努力正在創造新的機遇，並支持全球MMR疫苗市場的持續成長。

市場動態

各國政府、衛生機構和世界衛生組織正透過加強免疫規劃和實施疾病預防策略，加速麻疹-腮腺炎-德國德國麻疹(MMR) 疫苗市場的成長。人們對疫苗有效性的認知不斷提高、兒童免疫接種工作的擴大以及持續控制麻疹疫情的努力，都在推動對 MMR 疫苗的需求。醫療機構正在完善免疫基礎設施，而生產商則致力於推動疫苗生產和儲存技術，以改善已開發市場和新興市場的供應和取得途徑。

製藥公司正努力提高產能、加強分銷網路並改善免疫解決方案，以滿足全球日益成長的醫療保健需求。儘管取得了這些進展，但疫苗接種猶豫、供應鏈挑戰以及醫療保健服務取得的不平等現象仍然影響著市場成長。各國政府和產業相關人員正透過宣傳活動、官民合作關係以及改善免疫策略來克服這些挑戰。對醫療保健和國際免疫宣傳活動的投入增加，為麻疹、腮腺炎、德國麻疹 (MMR) 疫苗市場的持續發展創造了重大機會。

本次調查的主要特點

該研究重點關注各個細分市場的潛在商機，並為相關人員提供具有吸引力的投資提案矩陣。
本研究深入分析了市場促進因素、限制因素、機會、新興技術、產品創新、市場趨勢、區域展望以及主要市場參與企業採取的競爭策略。
本研究根據麻疹、腮腺炎和德國德國麻疹(MMR) 疫苗市場主要參與者的公司簡介、疫苗組合、近期發展、財務表現和策略舉措，進行分析。
透過利用本報告中的見解，行銷負責人、高階主管和經營團隊將能夠就未來的疫苗開發、生產擴張、技術採用、市場滲透、策略夥伴關係和商業化策略做出明智的決策。
麻疹、腮腺炎和德國德國麻疹(MMR) 疫苗市場報告的目標受眾廣泛，包括投資者、疫苗製造商、製藥公司、醫療保健提供者、政府機構、免疫規劃開發商、經銷商、研究機構、公共衛生組織、新市場參與企業和金融相關人員。
相關人員可以透過麻疹、腮腺炎和德國麻疹(MMR) 疫苗市場報告中提出的分析框架、競爭基準和市場估值矩陣做出明智的策略決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第7章競爭情勢

熱圖分析
市佔率分析
公司簡介
- GlaxoSmithKline（Belgium）
- Merck & Co. Inc.（USA）
- Serum Institute of India Ltd.
分析師意見

第8章

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI1496

Measles, Mumps and Rubella (MMR) Vaccines Market is estimated to be valued at USD 4.2 Bn in 2026 and is expected to reach USD 5.8 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.1% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 4.2 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	6.10%	2033 Value Projection:	USD 5.8 Bn

Governments and healthcare organizations are driving the growth of the Measles, Mumps, and Rubella (MMR) Vaccines market by strengthening immunization programs and preventing the spread of highly contagious viral infections. Healthcare providers administer MMR vaccines to stimulate immune protection against measles, mumps, and rubella while reducing disease transmission rates. Increasing public awareness about vaccination benefits, growing emphasis on preventive healthcare, and global initiatives to improve immunization coverage are encouraging the adoption of MMR vaccines among children, adolescents, and adults.

Government vaccination campaigns, rising healthcare investments, and advancements in vaccine development and distribution technologies are supporting the expansion of the MMR Vaccines market. Pharmaceutical companies are enhancing vaccine accessibility, optimizing storage and supply chain solutions, and improving manufacturing capabilities to meet the requirements of large-scale immunization programs. Public health organizations are increasing efforts to control measles outbreaks and improve vaccination rates through international health campaigns. These initiatives are creating new opportunities and supporting the continued growth of the global MMR vaccines market.

Market Dynamics

Governments, healthcare organizations, and global health agencies are accelerating the growth of the Measles, Mumps, and Rubella (MMR) Vaccines market by strengthening immunization programs and implementing disease prevention strategies. Increased awareness of vaccine effectiveness, expanding childhood immunization initiatives, and ongoing efforts to control measles outbreaks are driving demand for MMR vaccines. Healthcare providers are improving vaccination infrastructure, while manufacturers are advancing vaccine production and storage technologies to enhance availability and accessibility across developed and emerging markets.

Pharmaceutical companies are increasing manufacturing capabilities, strengthening distribution networks, and developing improved immunization solutions to meet rising global healthcare demands. Despite these advancements, vaccine hesitancy, supply chain challenges, and disparities in healthcare access continue to impact market expansion. Governments and industry players are overcoming these challenges by conducting awareness programs, establishing public-private partnerships, and improving vaccination strategies. Growing investments in preventive healthcare and international immunization campaigns are creating significant opportunities for the continued development of the MMR Vaccines market.

Key Features of the Study

It highlights potential revenue opportunities across various market segments and presents attractive investment proposition matrices for stakeholders.
This study provides key insights into market drivers, restraints, opportunities, emerging technologies, product innovations, market trends, regional outlook, and competitive strategies adopted by leading market participants.
It profiles key players in the Measles, Mumps and Rubella (MMR) Vaccines Market based on company overview, vaccine portfolio, recent developments, financial performance, and strategic initiatives.
Key companies covered as part of this study include GlaxoSmithKline (Belgium), Merck & Co. Inc. (USA) and Serum Institute of India Ltd.
Insights from this report enable marketers, business executives, and management teams to make informed decisions regarding future vaccine development, manufacturing expansion, technology adoption, market penetration, strategic partnerships, and commercialization strategies.
The Measles, Mumps and Rubella (MMR) Vaccines Market report serves a wide range of stakeholders, including investors, vaccine manufacturers, pharmaceutical companies, healthcare providers, government organizations, immunization program developers, distributors, research institutions, public health agencies, new market entrants, and financial analysts.
Stakeholders can make well-informed strategic decisions through the analytical frameworks, competitive benchmarking, and market assessment matrices presented in the Measles, Mumps and Rubella (MMR) Vaccines Market report.

Market Segmentation

By Product Type (Revenue, USD Bn, 2021-2033)
Monovalent
Combinational
Divalent
Trivalent
Others
By End Users (Revenue, USD Bn, 2021-2033)
Hospitals
Healthcare Centers
Others
By Region (Revenue, USD Bn, 2021-2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- South Africa
- Central Africa
- North Africa
Key Players
GlaxoSmithKline (Belgium)
Merck & Co. Inc. (USA)
Serum Institute of India Ltd.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By End Users
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Product Approval
Collaboration/Merge/Acquisition
Regulatory Landscape
PEST Analysis
Porter's Five Forces Analysis
Epidemiology
Robust Pipeline Analysis

4. Global Measles, Mumps and Rubella (MMR) Vaccines Market, By Product Type, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Monovalent
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Combinational
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Segment Trends
Divalent
Trivalent
Others

5. Global Measles, Mumps and Rubella (MMR) Vaccines Market, By End Users, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Healthcare Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

6. Global Measles, Mumps and Rubella (MMR) Vaccines Market, By Region, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Billion)
  - North Africa
  - Central Africa
  - South Africa

7. Competitive Landscape

Heat Map Analysis
Market Share Analysis
Company Profile
- GlaxoSmithKline (Belgium)
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Merck & Co. Inc. (USA)
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Serum Institute of India Ltd.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
Analyst Views